作者: Peter A. Newman
DOI: 10.1080/15381500903396857
关键词:
摘要: A safe and efficacious HIV vaccine would be a tremendous asset to halting the spread of HIV. Nevertheless, vaccines face range social behavioral challenges that will determine their ultimate contribution prevention. development clinical trials raise thorny social, behavioral, ethical issues around resource allocation, recruitment enrollment, trial implementation, post-trial follow-up access services. Furthermore, success future is contingent on acceptability. Involvement work service providers engagement science research across continuum dissemination are central successful community advocacy, mitigation harms trials, support for fair conduct acceptability vaccines, integration with